Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (261-270 of 312) with videos related to

Pageof 32
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2017
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 ResultsEriene A Youssef, Elizabeth Berry-Kravis, Christian Czech, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Progression of tremor and ataxia in male carriers of the FMR1 premutationMaureen A Leehey, Elizabeth Berry-Kravis, Sung-Joon Min, et al.
JAMA|January 30, 2004
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier populationSébastien Jacquemont, Randi J Hagerman, Maureen A Leehey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Development of genomic reference materials for Huntington disease genetic testingLisa Kalman, Monique A Johnson, Jeanne Beck, et al.
Clinical Interventions in Aging|August 9, 2008
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problemsRandi J Hagerman, Deborah A Hall, Sarah Coffey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2007
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelinesElizabeth Berry-Kravis, Liane Abrams, Sarah M Coffey, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 27, 2005
Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutationDavid Hessl, Flora Tassone, Danuta Z Loesch, et al.
Journal of Neurodevelopmental Disorders|August 25, 2025
Phenotypic variation in neural sensory processing by deletion size, age, and sex in Phelan-McDermid syndromeMelody Reese Smith, Elizabeth Berry-Kravis, Andrew Thaliath, et al.
Journal of Lipid Research|June 16, 2019
<i>N</i>-acyl-<i>O</i>-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 diseaseRohini Sidhu, Yawo Mondjinou, Mingxing Qian, et al.
Pageof 32

Showing results (261-270 of 312) with videos related to

Sort By:
Pageof 32
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 18, 2017
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 ResultsEriene A Youssef, Elizabeth Berry-Kravis, Christian Czech, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Progression of tremor and ataxia in male carriers of the FMR1 premutationMaureen A Leehey, Elizabeth Berry-Kravis, Sung-Joon Min, et al.
JAMA|January 30, 2004
Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier populationSébastien Jacquemont, Randi J Hagerman, Maureen A Leehey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 13, 2007
Development of genomic reference materials for Huntington disease genetic testingLisa Kalman, Monique A Johnson, Jeanne Beck, et al.
Clinical Interventions in Aging|August 9, 2008
Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problemsRandi J Hagerman, Deborah A Hall, Sarah Coffey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 10, 2007
Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelinesElizabeth Berry-Kravis, Liane Abrams, Sarah M Coffey, et al.
Nature Reviews. Drug Discovery|May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunitiesMichelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 27, 2005
Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutationDavid Hessl, Flora Tassone, Danuta Z Loesch, et al.
Journal of Neurodevelopmental Disorders|August 25, 2025
Phenotypic variation in neural sensory processing by deletion size, age, and sex in Phelan-McDermid syndromeMelody Reese Smith, Elizabeth Berry-Kravis, Andrew Thaliath, et al.
Journal of Lipid Research|June 16, 2019
<i>N</i>-acyl-<i>O</i>-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 diseaseRohini Sidhu, Yawo Mondjinou, Mingxing Qian, et al.
Pageof 32